ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.640
+0.050 (3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.060 (3.66%)
After-hours: Apr 28, 2026, 5:32 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $220.68 million as of April 28, 2026. Its market cap has increased by 761.20% in one year.
Market Cap
220.68M
Enterprise Value
182.58M
1-Year Change
761.20%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $220.68M, a decrease of -79.11%. That is a compound annual growth rate of -23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 213.95M | 249.21% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |
| Milestone Pharmaceuticals | 231.81M |
| Camp4 Therapeutics | 230.52M |
| Polaryx Therapeutics | 229.61M |
| Keros Therapeutics | 226.95M |
| Voyager Therapeutics | 225.88M |
| Heron Therapeutics | 224.48M |